Jennifer Ruddock

Chief Business Officer @ Nektar Therapeutics arrow icon

About Jennifer Ruddock

Jennifer Ruddock is the Chief Business Officer at Nektar, responsible for multiple corporate functions and has extensive experience in investor relations and corporate marketing.

Known information

Jennifer Ruddock serves as the Chief Business Officer at Nektar, a position she has held since joining the company in 2004. In her role, she oversees investor relations, business development, corporate marketing, corporate and employee communications, and public and government affairs functions. Prior to Nektar, Ruddock held leadership roles at Catellus Development Corporation and Tumbleweed Communications, focusing on investor relations, financial communications, and corporate marketing. Her earlier career included a specialization in high technology and healthcare sectors at Montgomery Securities, and she began her professional journey in medical device sales at Curtin Matheson Scientific. Ruddock also contributes to several boards and committees; she serves on the Board of Directors of the California Life Sciences Association, is a member of the Public Policy Committee of the San Francisco Chamber of Commerce, and is a board member of the San Francisco Foster Youth Fund. She earned a B.A. in neuroscience from Colgate University in 1991.

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company focused on developing novel therapies that modulate the immune system to treat autoimmune disorders, chronic inflammatory conditions, and cancer.

report flag Report inaccurate information

People similar to Jennifer Ruddock

Robert Bacci

Senior Vice President, HR and Facilities Operations @ Nektar Therapeutics

Robert Bacci is the Senior Vice President of HR and Facilities Operations at Nektar, with a strong background in industrial hygiene and environmental risk assessments.

Sandra Gardiner

Chief Financial Officer @ Nektar Therapeutics

Sandra Gardiner is a seasoned business and finance executive with over 30 years of experience, currently serving as CFO and Partner at FLG Partners and previously holding multiple CFO roles in global companies.

Mark A. Wilson is the Chief Legal Officer with a background in pharmacy and law, specializing in patent law and registered to practice before the U.S. Patent and Trademark Office.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free